The Food and Drug Administration granted market clearance for ResMed's AirMini device.
The AirMini is a small, portable continuous positive airway pressure device for patients with sleep apnea.
The device is intended for use as a secondary CPAP for individuals to maintain sleep apnea therapy while traveling, according to a news release.
San Diego-based ResMed expects to launch the device later this year.
More articles on supply chain:
6 noteworthy drugs the FDA approved in 2016
HHS Sec. Burwell's advice to Dr. Tom Price: Prioritize cybersecurity
Valeant to sell off $2B in assets to ease debt: 3 takeaways